Feb 17, 2025 · Besifloxacin ophthalmic (for the eyes) is an antibiotic medication that is used to treat bacterial infections of the eyes. Besifloxacin ophthalmic may also be used for purposes not listed in this medication guide.

Besifloxacin (INN/USAN) is a fourth-generation fluoroquinolone antibiotic. The marketed compound is besifloxacin hydrochloride. It was developed by SSP Co. Ltd., Japan, and designated SS734. SSP licensed U.S. and European rights to SS734 for ophthalmic use to InSite Vision Incorporated (OTC Pink: INSV) in 2000.

Easy-to-read patient leaflet for Besifloxacin. Includes indications, proper use, special instructions, precautions, and possible side effects.

Besifloxacin ophthalmic (eye) preparation is used to treat infections of the eye, such as bacterial conjunctivitis. Besifloxacin belongs to a group of medicines called fluoroquinolone antibiotics. It works by killing bacteria that cause conjunctivitis.

Nov 17, 2024 · Besivance (besifloxacin) is commonly used to treat conjunctivitis (pink eye), which is a condition where part of your eye is inflamed possibly due to bacteria. Besivance may not be...

Besifloxacin ophthalmic is used to treat bacterial conjunctivitis (pinkeye; infection of the membrane that covers the outside of the eyeballs and the inside of the eyelids). Besifloxacin is in a class of medications called fluoroquinolones. It works by killing the bacteria that cause infection.

Sep 14, 2010 · Besifloxacin is a bactericidal fluroquinolone-type antibiotic that inhibits bacterial enzymes, DNA gyrase and topoisomerase IV. By inhibiting DNA gyrase, DNA replication, transcription, and repair is impaired.

May 1, 2024 · Besivance (besifloxacin) is used to treat bacterial infections of the eyes. Includes Besivance side effects, interactions and indications.

Jun 30, 2024 · Besivance is a prescription eye drop used to treat bacterial pink eye in adults and children 1 year of age and older. It belongs to the fluoroquinolone antibiotic class. The dosage is typically 1 drop three times per day for 7 days to treat the eye infection.

This comprehensive review summarizes the mechanism of action, pharmacokinetics, efficacy, and safety of besifloxacin ophthalmic suspension, 0.6% and examines its role in the treatment of ocular surface bacterial infections. Besifloxacin possesses ...